Friday, 29 March 2024


Japan's IDA selects OmniComm Systems' clinical data management solution

16 June 2015 | News | By BioSpectrum Bureau

Japan's IDA selects OmniComm Systems' clinical data management solution

OmniComm Systems Inc., a provider of clinical data management technology, announces the selection of the company's Promasys EDC by Integrated Development Associates (IDA), a Tokyo-based Pan Asian drug development company, to run clinical trials in Japan and the Philippines.

Japan represents the second largest pharmaceutical market in the world whereas Philippines is considered to be one of the fastest growing markets.

OmniComm Systems believes that its Promasys system is an important tool that will allow the company to offer its clients with data management and EDC services in a highly reliable and cost efficient manner.

Integrated Development Associates Co. Ltd. (IDA), founded in 2004 and a member of the M3 Group since March 2015, is a Japanese company that provides consulting, CRO and IT driven solutions that enable the optimal development and commercialization of novel biopharmaceutical products for Japan and Asia. IDA's business model enables companies to increase the value of their products through intelligent product development planning, accelerated clinical trial implementation and effective marketing strategies.

"As IDA grows, we see not only the need to integrate Japan into large global studies but also the need to efficiently deliver turn-key Phase I ethnic bridging studies and stand-alone local Japan and Pan Asian clinical trials for clients," said John Winebarger, President and CEO, IDA.

After a thorough evaluation process of various commercially available technologies, IDA selected Promasys technology to manage its clinical data management activities. Overall Promasys was deemed to be best suited in terms of ease of use, fast study build, data quality and integrity and subject recruitment.

"OmniComm already has a strong presence in East Asia with an increasing number of customers in China, Korea and Japan," said Wolf Ondracek, Senior Vice President of Asian and Academic Markets at OmniComm. "Now that IDA have selected Promasys as the solution for their local and international data capture and data management needs, we will not only further strengthen our presence in the strategic Japanese market, but also enter the Philippines which is a new but important territory. We are proud that our software will be used at the Phase I facilities within the prestigious De La Salle Health Sciences Institute in Dasmariñas, as well as with IDA Japanese and their Pan Asian Phase I-IV clinical trials."

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account